Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice

H Matsuda, H Koyama, H Sato, J Sawada, A Itakura, A Tanaka, M Matsumoto, K Konno, H Ushio, K Matsuda, H Matsuda, H Koyama, H Sato, J Sawada, A Itakura, A Tanaka, M Matsumoto, K Konno, H Ushio, K Matsuda

Abstract

Four full-thickness skin wounds made in normal mice led to the significant increase in levels of nerve growth factor (NGF) in sera and in wounded skin tissues. Since sialoadenectomy before the wounds inhibited the rise in serum levels of NGF, the NGF may be released from the salivary gland into the blood stream after the wounds. In contrast, the fact that messenger RNA and protein of NGF were detected in newly formed epithelial cells at the edge of the wound and fibroblasts consistent with the granulation tissue produced in the wound space, suggests that NGF was also produced at the wounded skin site. Topical application of NGF into the wounds accelerated the rate of wound healing in normal mice and in healing-impaired diabetic KK/Ta mice. This clinical effect of NGF was evaluated by histological examination; the increases in the degree of reepithelialization, the thickness of the granulation tissue, and the density of extracellular matrix were observed. NGF also increased the breaking strength of healing linear wounds in normal and diabetic mice. These findings suggested that NGF immediately and constitutively released in response to cutaneous injury may contribute to wound healing through broader biological activities, and NGF improved the diabetic impaired response of wound healing.

Figures

Figure 1
Figure 1
Serum NGF levels in male SJL/J mice after cutaneous wounding. Each point represents the mean ± SE of three separate experiments using duplicate samples.
Figure 2
Figure 2
NGF levels at the wounded skin site (closed) and control unwounded skin site (open) of male SJL/J mice after cutaneous wounding. Each point represents the mean ± SE of three separate experiments using duplicate samples.
Figure 3
Figure 3
Cellular localization of mRNA and protein of NGF in newly formed epithelium at edge of the wound (B and F, original magnification: 240) and granulation tissue produced in the wound space (D and H, original magnification: 550). All specimens were obtained from male SJL/J mice 3 d after cutaneous wounding. Basal cells of the epidermis show positive reaction for mRNA expression of NGF (B) and superficial epithelial cells show positive reaction for protein of NGF (F). Positive reaction for both the mRNA (D) and protein (H) of NGF is observed in fibroblasts in the granulation tissue. No positive reactions are observed in the sections treated with the sense primer (A and C) and the irrelevant Ab instead of anti-NGF Ab (E and G).
Figure 4
Figure 4
Production of NGF by 3T3 fibroblasts stimulated with various cytokines and histamine. NGF levels in culture medium were measured by a sandwich ELISA as described in Materials and Methods. Each point represents the mean ± SE of three separate experiments using duplicate samples.
Figure 5
Figure 5
Production of NGF by PAM 212 keratinocytes stimulated with various cytokines and histamine. NGF levels in culture medium were measured by a sandwich ELISA as described in Materials and Methods. Each point represents the mean ± SE of three separate experiments using duplicate samples.
Figure 6
Figure 6
Wound healing accelerated by topical applications of NGF in control C57BL/6 mice and diabetic KK/Ta mice. NGF (1 μg) or vehicle solution alone was applied to the wound space each day for 3 d beginning with the day of wounding as described in Materials and Methods, and a healing term was examined macroscopically. Each histogram represents the mean ± SE of six mice per group. *P <0.02; ‡P <0.01; when compared with diluent alone.
Figure 7
Figure 7
Histological features of wound specimens from control C57BL/6 mice (A and B) and diabetic KK/Ta mice (C and D) 8 d after cutaneous wounding. NGF (1 μg; B and D) or vehicle solution alone (A and C) was applied to the wound space each day for 3 d beginning with the day of wounding as described in Materials and Methods. Sections were stained with hematoxylin and eosin. Original magnification: 60. Arrow heads, the original wound margin.
Figure 8
Figure 8
Effects of NGF on wound tear strength in control C57BL/6 mice and diabetic KK/ Ta mice. NGF (2 μg) or vehicle solution alone was applied to the wound space shortly after the wounding, and wound tear strength was measured as described in Materials and Methods. Each histogram represents the mean ± SE of four mice per group. *P <0.01; when compared with diluent alone.

References

    1. Clark, R.A.F. 1996. Wound repair: overview and general considerations. In The Molecular and Cellular Biology of Wound Repair. R.A.F. Clark, editor. Plenum Press, New York. 3–50.
    1. Martin P. Wound healing–aiming for perfect skin regeneration. Science. 1997;276:75–81.
    1. Pierce GF, Mustoe TA. Pharmacologic enhancement of wound healing. Annu Rev Med. 1995;46:467–481.
    1. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg. 1993;165:728–737.
    1. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol. 1995;68:1–7.
    1. Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth factor stimulates wound healing-impaired db/dbmice. J Exp Med. 1991;172:245–251.
    1. Brown RE, Breeden MP, Greenhalgh DG. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res. 1994;56:562–570.
    1. Siegel, J. 1995. Diabetes mellitus. In Perspectives on Pathophysiology. L.-E.C. Copstead, editor. W.B. Saunders Company, Philadelphia. 826–845.
    1. Kasayama S, Oka T. Impaired production of nerve growth factor in the submandibular gland of diabetic mice. Am J Physiol. 1989;257:E400–E404.
    1. Ordonez G, Fernandez A, Perez R, Sotelo J. Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. A possible etiological element of diabetic neuropathy. J Neurol Sci. 1994;121:163–166.
    1. Faradji V, Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand. 1990;81:402–406.
    1. Anand P. Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci. 1996;351:449–454.
    1. Levi-Montalcini R, Angeletti PU. Essential role of the nerve growth factor on the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev Biol. 1963;7:653–659.
    1. Thoenen H, Edgar D. Neurotrophic factors. Science. 1985;229:238–242.
    1. Korsching S. The role of nerve growth factor in the CNS. Trends Neurosci. 1986;9:570–577.
    1. Gee AP, Boyle MDP, Munger L, Lawman MJP, Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci USA. 1983;80:7215–7218.
    1. Pearce FL, Thompson HL. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol (Lond) 1986;372:379–393.
    1. Thorpe LW, Perez-Polo JR. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res. 1987;18:134–139.
    1. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA. 1989;86:10059–10063.
    1. Kannan Y, Ushio H, Koyama H, Okada M, Oikawa M, Yoshihara T, Kaneko M, Matsuda H. 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood. 1991;77:1320–1325.
    1. Susaki Y, Shimizu S, Katakura K, Watanabe N, Kawamoto K, Matsumoto M, Tsudzuki M, Furusaka T, Kitamura Y, Matsuda H. Functional properties of murine macrophages promoted by nerve growth factor. Blood. 1996;88:4630–4637.
    1. Hamada A, Watanabe N, Ohtomo H, Matsuda H. Nerve growth factor enhances survival and cytotoxic activity of human eosinophils. Br J Haematol. 1996;93:299–302.
    1. Sutter A, Riopelle RJ, Harris-Warrick RM, Shooter EM. Nerve growth factor receptors: characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells. J Biol Chem. 1979;254:4972–4982.
    1. Yanker BA, Shooter EM. The biology and mechanism of action of nerve growth factor. Annu Rev Biochem. 1982;51:845–868.
    1. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF. The trkproto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 1991;252:554–558.
    1. Matsuda H, Coughlin MD, Bienenstock J, Denburg JA. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA. 1988;85:6508–6512.
    1. Matsuda H, Switzer J, Coughlin MD, Bienenstock J, Denburg JA. Human basophilic cell differentiation promoted by 2.5S nerve growth factor. Int Arch Allergy Immunol. 1988;86:453–457.
    1. Kannan Y, Matsuda H, Ushio H, Kawamoto K, Shimada Y. Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor. Int Arch Allergy Immunol. 1993;132:362–367.
    1. Kannan Y, Usami K, Okada M, Shimizu S, Matsuda H. Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem Biophys Res Commun. 1992;186:1050–1056.
    1. Kawamoto K, Okada T, Kannan Y, Ushio H, Matsumoto M, Matsuda H. Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trkproto-oncogene receptor. Blood. 1995;86:4638–4644.
    1. Matsuda H, Kannan Y, Ushio H, Kiso Y, Kanemoto T, Suzuki H, Kitamura Y. Nerve growth factor induces development of connective tissue–type mast cells in vitro from murine bone marrow cells. J Exp Med. 1991;174:7–14.
    1. Young M, Ofer J, Blanchard MH, Asdourian H, Amos H, Arnason BGW. Secretion of a nerve growth factor by primary chick fibroblast cultures. Science. 1974;187:361–362.
    1. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212) J Clin Invest. 1990;85:1085–1089.
    1. Leon, A., A. Buriani, R. dal Toso, M. Fabris, S. Romanello, L. Aloe, and R. Levi-Montalcini. 1994. Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. USA. 91:3739–3743.
    1. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci USA. 1993;90:10984–10988.
    1. Denon D, Kowatch MA, Roth GS. Production of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA. 1989;86:2018–2020.
    1. Scott J, Selby M, Uredea M, Quiriga M, Bell GI, Rutter WJ. Isolation and nucleotide sequence of cDNA encoding the precursor of mouse nerve growth factor. Nature. 1983;302:538–540.
    1. Humpel C, Lindqvidst E, Olson L. Detection of nerve growth factor mRNA in rodent salivary glands with digoxigenin- and 32P-labeled oligonucleotides: effects of castration and sympathectomy. J Histochem Cytochem. 1993;41:703–708.
    1. Nakamura M, Yamada K. Studies on a diabetic (KK) strain of the mouse. Diabetologia. 1967;3:212–221.
    1. Reddi AS, Camerini-Davalos RA. Hereditary diabetes in the KK mouse: an overview. Adv Exp Med Biol. 1988;246:7–15.
    1. Hasegawa M, Ogawa Y, Katsuura G, Shintaku H, Hosoda K, Nakano K. Regulation of obese gene expression in KK mice and congenic lethal yellow obese KKAy mice. Am J Physiol. 1996;271:E333–E339.
    1. Aloe L, Alleva E, Bohn A, Levi-Montalcini R. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci USA. 1986;83:6184–6187.
    1. Ehrhard PB, Ganter U, Bauer J, Otten U. Expression of functional trkprotooncogene in human monocytes. Proc Natl Acad Sci USA. 1993;90:5423–5427.
    1. Bischoff S, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood. 1992;792:2662–2669.
    1. Torcia M, Bracci-Laudiero L, Lusibello M, Nencioni L, Labardi D, Rubartelli A, Cozzolino F, Aloe L, Garaci E. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 1996;85:345–356.
    1. Liu HM, Lei HY, Kao KP. Correlation between NGF levels in wound chamber fluid and cytological location of NGF and NGF receptor in axotomized rat sciatic nerve. Exp Neurol. 1995;132:24–32.
    1. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 1987;330:658–659.
    1. Lindholm D, Heumann R, Hengerer B, Thoenen H. Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J Biol Chem. 1988;263:16348–16351.
    1. Paus R, Luftle M, Czarnetzki BM. Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol. 1994;130:174–180.
    1. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, De Luca M. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem. 1993;268:22838–22846.
    1. Buckley-Sturrock A, Woodward SC, Senior RM, Griffin GL, Klagsbrun M, Davidson JM. Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol. 1989;138:70–78.
    1. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45:319–326.
    1. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Flalnga V, Kehrl JH, Fauci AS. Transforming growth factor type B: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. . Proc Natl Acad Sci USA. 1986;83:4167–4171.
    1. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 1994;634:7–12.

Source: PubMed

3
Abonner